Raffaele Colombo: New AACR D3 Conference Focuses on Drug Discovery and Development

Raffaele Colombo, Director of Medicinal Chemistry at Zymeworks Inc., shared a post by American Association for Cancer Research on LinkedIn:

“Can’t miss the new AACR D3 conference on Drug Discovery and Development!

Join us July 21-24 in Boston!”

Quoting AACR‘s post:

“Register by June 10 to get the lowest rates for the AACR D3 Conference on Drug Discovery and Development (July 21-24; Boston), chaired by AACR President Keith T. Flaherty, Lillian L. Siu, Patricia M. LoRusso, and Timothy A. Yap.

Learn more.”

Other articles about AACR on OncoDaily.